Genome Biology (Oct 2023)

Landscape of enhancer disruption and functional screen in melanoma cells

  • Zhao Wang,
  • Menghan Luo,
  • Qian Liang,
  • Ke Zhao,
  • Yuelin Hu,
  • Wei Wang,
  • Xiangling Feng,
  • Bolang Hu,
  • Jianjin Teng,
  • Tianyi You,
  • Ran Li,
  • Zhengkai Bao,
  • Wenhao Pan,
  • Tielong Yang,
  • Chao Zhang,
  • Ting Li,
  • Xiaobao Dong,
  • Xianfu Yi,
  • Ben Liu,
  • Li Zhao,
  • Miaoxin Li,
  • Kexin Chen,
  • Weihong Song,
  • Jilong Yang,
  • Mulin Jun Li

DOI
https://doi.org/10.1186/s13059-023-03087-5
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 32

Abstract

Read online

Abstract Background The high mutation rate throughout the entire melanoma genome presents a major challenge in stratifying true driver events from the background mutations. Numerous recurrent non-coding alterations, such as those in enhancers, can shape tumor evolution, thereby emphasizing the importance in systematically deciphering enhancer disruptions in melanoma. Results Here, we leveraged 297 melanoma whole-genome sequencing samples to prioritize highly recurrent regions. By performing a genome-scale CRISPR interference (CRISPRi) screen on highly recurrent region-associated enhancers in melanoma cells, we identified 66 significant hits which could have tumor-suppressive roles. These functional enhancers show unique mutational patterns independent of classical significantly mutated genes in melanoma. Target gene analysis for the essential enhancers reveal many known and hidden mechanisms underlying melanoma growth. Utilizing extensive functional validation experiments, we demonstrate that a super enhancer element could modulate melanoma cell proliferation by targeting MEF2A, and another distal enhancer is able to sustain PTEN tumor-suppressive potential via long-range interactions. Conclusions Our study establishes a catalogue of crucial enhancers and their target genes in melanoma growth and progression, and illuminates the identification of novel mechanisms of dysregulation for melanoma driver genes and new therapeutic targeting strategies.

Keywords